Author

Zhichao Tan

Institution: Peking University Cancer Hospital

Observed institution: Peking University Cancer Hospital

OpenAlex ID: A5137125124

FDA-approved fulvestrant-induced CAR phase separation enables precise control of CAR T antitumor function

2026 · Yuwei Huang, Qichen Zhang, et al. · Cell stem cell · 1

Preliminary results of pegylated liposomal doxorubicin, dacarbazine, and toripalimab in patients with advanced primary cardiac sarcoma: An interim analysis.

2026 · Zhichao Tan, Jiayong Liu, et al. · Journal of Clinical Oncology

Camrelizumab combined with liposomal doxorubicin and dacarbazine as first-line therapy for advanced, recurrent, and metastatic undifferentiated pleomorphic sarcoma: A phase II study.

2026 · Tian Gao, Jiayong Liu, et al. · Journal of Clinical Oncology

Works count: 3

Citation count: 1

H-index: 1

I10-index: